60 DEGREES PHARMACEUTICALS, INC.
60 DEGREES PHARMACEUTICALS, INC. (SXTP): 3 pipeline candidates · 1 upcoming catalyst · ~5 mo cash runway · 4 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
4.6 months
D/E 0.42 · 0% dilution
Lead: Approved
3 candidates
1 upcoming, next in ~3454d
N/A
A transparent, data-derived signal for 60 DEGREES PHARMACEUTICALS, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$4.5M
Cash
$3.3M
Quarterly Burn
$2.7M
Runway
4.6 mo
Revenue
$162K
Cash Runway vs Catalysts
A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.
Pipeline (3 candidates)
| Drug | Phase |
|---|---|
| arakoda | Approved |
| celgosivir | Preclinical |
| tafenoquine | Phase 2 |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
6
Total value held
$285K
| Holder | Shares | Value |
|---|---|---|
| kathmere capital management, llc | 144,683 | $253K |
| geode capital management, llc | 16,295 | $29K |
| barclays plc | 1,856 | $3K |
| osaic holdings, inc. | 25 | $43 |
| twin peaks wealth advisors, llc | 8 | $14 |
| citigroup inc | 1 | $2 |
Frequently asked questions
How many drug candidates are in 60 DEGREES PHARMACEUTICALS, INC.'s pipeline?
60 DEGREES PHARMACEUTICALS, INC. (SXTP) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is 60 DEGREES PHARMACEUTICALS, INC.'s lead drug candidate?
60 DEGREES PHARMACEUTICALS, INC.'s most advanced tracked candidate is arakoda (Approved) for Malaria prevention.
What is 60 DEGREES PHARMACEUTICALS, INC.'s next catalyst?
60 DEGREES PHARMACEUTICALS, INC.'s next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: ARAKODA" — expected December 2, 2035.
What is 60 DEGREES PHARMACEUTICALS, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, 60 DEGREES PHARMACEUTICALS, INC. has approximately 4.6 months of cash runway.
What is 60 DEGREES PHARMACEUTICALS, INC.'s market capitalization?
60 DEGREES PHARMACEUTICALS, INC.'s market capitalization is approximately $4.5M.
Get the full picture on 60 DEGREES PHARMACEUTICALS, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.